Genomenon
Latest round
- Series B
Last raised
- Feb 2022
Total raised
- $31M
Investors
- 17
About Genomenon
Genomenon, Inc.Founded in 2014 and headquartered in Ann Arbor, Michigan, Genomenon specializes in genomic data solutions. The firm has undergone significant growth and development in its operations. The firm was co-founded by Mark Kiel and Steve Schwartz, with Mike Klein serving as the CEO.Genomenon offers a suite of genomic data solutions centered around the Mastermind Genomic Intelligence Platform, which utilizes artificial intelligence for analyzing and interpreting extensive genomic datasets. The platform supports rapid search capabilities and insights into genomic literature for both germline and somatic variant interpretation. Additionally, Genomenon provides a Cancer Knowledgebase that assists in interpreting cancer variants by linking them to relevant therapies and clinical trials.Genomenon generates revenue through software subscriptions and consulting services. Clients primarily engage with the Mastermind platform on a subscription model, gaining access to advanced genomic analysis features. The company also provides tailored consulting services, often forming long-term partnerships with research institutions and healthcare providers.In February 2022, Genomenon, Inc. Upcoming initiatives include the introduction of new features for the Mastermind platform aimed at improving user experience and genomic analysis capabilities. Genomenon is also targeting expansion into additional markets across Europe and Asia, with specific plans for geographic growth to be outlined by the end of 2023.
Who invested in Genomenon
17 investors across 6 rounds
See all investors in Genomenon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genomenon
Who invested in Genomenon?
Genomenon has 17 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genomenon raised?
Genomenon has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Genomenon last raise money?
Genomenon's most recent round on record is a Series B, in Feb 2022.
What does Genomenon do?
Genomenon is a software company.
Where is Genomenon headquartered?
Genomenon is headquartered in Ann Arbor, US.
Which VCs invest in companies like Genomenon?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Genomenon's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like Genomenon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.